MBD Biotech

Suwon, South Korea Founded: 2015 • Age: 11 yrs
Provider of drug efficacy and toxicity testing services

About MBD Biotech

MBD Biotech is a Healthcare company based in Suwon (South Korea) founded in 2015. Provider of drug efficacy and toxicity testing services. Its chief executive, as recorded, is Bo Sung Ku. MBD Biotech offers products and services including Cellvitro, ASFA Spotter, and ASFA Scanner. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Analytical Testing. Its legal entity is MBD Inc.

Company details

MBD Biotech was founded in 2015 in Suwon-si, South Korea, within the biotechnology sector. Drug efficacy and toxicity testing services are offered using a proprietary Cellvitro chip structure featuring pillars and wells. Dispenser and scanning machines, branded ASFA, have been developed to support 3D cell cultures encapsulated in hydrogel, facilitating predictions of drug interactions and reactivity in the human body.

  • Headquarters Suwon, South Korea
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website mbdbiotech.com
  • Legal Name Mbd Inc.

Products & Services of MBD Biotech

MBD Biotech offers a comprehensive portfolio of products and services, including Cellvitro, ASFA Spotter, and ASFA Scanner.

Cellvitro
Cell Culture Tool

3D cell culture chip for precision medicine research.

ASFA Spotter
Liquid Spotter

Accurate liquid spotting device for laboratory use.

ASFA Scanner
Analytical Scanner

Scanner for analyzing samples in drug development.

People of MBD Biotech

1 people are tracked at MBD Biotech (1 in leadership).

NameRoleGroup
Bo Sung Ku
CEOLeadership
Premium access

Complete people profiles for MBD Biotech

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Web traffic of MBD Biotech

The website of MBD Biotech (mbdbiotech.com) receives about 3.2K visits a month.

  • Monthly visits
    3.2K

    ▼ 16.5% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Mbd Biotech

Premium access

Complete news archive for MBD Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about MBD Biotech

MBD Biotech was founded in 2015.

MBD Biotech is headquartered in Suwon, South Korea. It is registered at Suwon, Gyeonggi, South Korea.

Bo Sung Ku is the CEO of MBD Biotech, as recorded in our data.

MBD Biotech was founded in 2015 in Suwon-si, South Korea, within the biotechnology sector. Drug efficacy and toxicity testing services are offered using a proprietary Cellvitro chip structure featuring pillars and wells. Dispenser and scanning machines, branded ASFA, have been developed to support 3D cell cultures encapsulated in hydrogel, facilitating predictions of drug interactions and reactivity in the human body.

MBD Biotech offers Cellvitro, ASFA Spotter, and ASFA Scanner.

MBD Biotech operates through Mbd Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available